Mérieux Equity Partners and Korys announce the launch of a new investment platform in Venture Capital to support innovative companies in the healthcare and nutrition sectors, in Europe and North America. OMX Europe Venture Fund FPCI (“OMX Europe”) was launched with a significant financial commitment representing more than two thirds of the target size of […]

Company to provide 50 Ion Torrent Genexus Systems for consortia members at a subsidized price to support global COVID-19 research CARLSBAD, Calif. — To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific today announces the SARS-CoV-2 GlobalAccess Sequencing Program for research consortia and industry groups battling the spread of the […]

Philadelphia-based Initiative Will Facilitate SARS-CoV-2 Research to Develop Antiviral Therapy for COVID-19 Using RNA Silencing FANA ASO Technology PHILADELPHIA  — The coronavirus pandemic has significantly disrupted life in most countries around the globe, causing a severe health and economic crisis. AUM LifeTech, Inc., a preclinical stage biotech company developing RNA therapeutics, and AUM BioTech, LLC, […]

New Ion AmpliSeq SARS-CoV-2 Research Panel, now optimized for the Ion Torrent Genexus System*, assists with contact tracing to identify coronavirus hot spots CARLSBAD, Calif. — As countries begin to ease restrictions and allow some businesses to reopen, contact tracing and epidemiological studies will be critical to understand resurgence of potential COVID-19 outbreaks. Scientists not only […]

Technology Advances Rapid, Cost-effective DNA Sequencing on Portable Devices SAN DIEGO, Calif. and LEUVEN, BELGIUM — Roswell Biotechnologies, Inc., the leader in molecular electronics sensor chips, and imec, a world-leading research and innovation hub in nanoelectronics and digital technologies,  announced today a partnership to develop the first commercially available molecular electronics biosensor chips. These chips are the brains […]

ST. LOUIS & AUGSBURG, Germany PierianDx, the leading clinical genomics informatics company, and University Hospital of Augsburg today announced a strategic development partnership to optimize an interpretation and reporting workflow based on the PierianDx Clinical Genomics Workspace™ platform for the AmpliSeq for Illumina Myeloid and Focus assays. Under the agreement, University Hospital of Augsburg will […]

Herlev, Denmark Today, Samplix launched its comprehensive service program to grant any laboratory access to the advantages of Xdrop™ technology. By partnering with the Samplix Service Team, researchers can leverage the unique Xdrop™ approach to address complex genomic questions, including gap closing, sequencing of repeat elements, detecting viral insertion sites, revealing unintended CRISPR edits, and […]

The Naica™ system, Stilla Technologies’ innovative digital PCR solution, combined with a Covid-19 detection kit, is able to quickly, accurately and reliably identify the SARS-CoV-2 virus, which is responsible for Covid-19, as well as measure its viral load. At the moment, the Naica system is mainly being used for research, and the company plans on expanding its use to diagnosis. Paris — Stilla Technologies, a leading French provider of pioneering solutions for high-precision genetic analyses, just announced that its […]

ANN ARBOR, Mich. — Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), announced the release of its Swift Amplicon SARS-CoV-2 Research Panel. Targeting the full viral genome in a single reaction with a rapid 2-hour workflow, Swift’s assay meets research and surveillance needs for standard samples […]

London, UK –  The UK genomic tools developer, RevoluGen Ltd., has appointed Sir John Chisholm as non-executive Chairman. Sir John was most recently Executive Chairman of Genomics England in which role he oversaw the world leading 100,000 Genome Project, which led to the UK being the first country to introduce Genomic Medicine into its health system. […]